Meloxicam Goodwill (Meloxicam)

Meloxicam works by reversibly inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2, with a greater effect on COX‑2. This reduces the synthesis of prostaglandins, which are key mediators of inflammation, pain, and fever, thereby providing analgesic and anti‑inflammatory effects.

The specific dose of Meloxicam Goodwill is determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. Healthcare professionals adjust the dose to achieve optimal pain control while minimizing potential risks.

Safety data for meloxicam in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To request Meloxicam Goodwill, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and required import documentation.

Meloxicam offers preferential COX‑2 inhibition, which may provide similar analgesic efficacy with a potentially lower incidence of gastrointestinal side effects compared with non‑selective NSAIDs like ibuprofen or naproxen. However, individual response varies, and clinicians consider patient‑specific factors when selecting an NSAID.

Meloxicam Goodwill should be stored at 2‑8 °C in a refrigerator, protected from light. The product must not be frozen or shaken vigorously. Keep the vial in its original packaging until ready for use to maintain stability.

Meloxicam Goodwill is supplied as an injectable solution for intramuscular injection. A qualified healthcare professional administers the dose into a suitable muscle, typically the gluteal or deltoid region, following aseptic technique and the prescriber’s instructions.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as myocardial infarction or stroke, acute renal impairment, severe skin reactions (e.g., Stevens‑Johnson syndrome), hepatic dysfunction, and anaphylaxis. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Meloxicam Goodwill is contraindicated in patients with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal ulceration or bleeding, severe renal or hepatic impairment, and individuals who have experienced a recent cardiovascular event. It should also be avoided in patients taking certain anticoagulants or other NSAIDs without medical supervision.